Shane E. Brogan
Rating: 4.9 of 5
( out of 123 reviews )

Shane E. Brogan, MD

Languages spoken: Irish, English, French

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

1950 Circle of Hope
Salt Lake City , UT 84112
801-587-7000
Get Directions

Pain Management Center

615 Arapeen Dr.
Salt Lake City , UT 84108
801-581-7246
Get Directions

University of Utah Hospital

Anesthesiology
50 N Medical Dr
Salt Lake City , UT 84132
801-581-6393
Get Directions

  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Specialties

    Board Certification

    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 123 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    September 19, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Brogan was very exceptional in explaining what I need how to get through it and how I can move forward.

    June 14, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Extremely kind compassionate

    June 13, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Thank you for all your hlep and kindness in my behalf.

    June 07, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Pain relief this man understands. Help me out tremendously.

    May 08, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr Brogan is very friendly, courteous and positive. He is very knowledgeable about his field.

    April 28, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    I was only scheduled for a nurse visit and was so greatly surprised that the dr seen me and came in to discuss my case. I am completely pleased to have Shane on my care team, I feel I'm in great hands

    April 10, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He is very knowledgeable and good beside manners

    March 25, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    He was very concerned about my pain. His team's questions were very thorough and my pain has been alleviated.

    March 13, 2025
    HUNTSMAN CANCER CENTER
    Rating: 5 out of 5

    Dr. Brogan is very very good. Id recommend him to anyone.

    See More Patient Comments

  • Shane E. Brogan, MB BCh, is a professor of Anesthesiology at the University of Utah School of Medicine, and pain physician at Huntsman Cancer Institute. Dr. Brogan's clinical and research interests are in the management of complex cancer pain and cancer survivor pain. As a member of the Huntsman Cancer Intstitute Supportive Oncology and Survivorship team, Dr Brogan works with patients to provide advanced cancer pain management with an emphasis on restoration of quality of life. Dr Brogan's areas of expertise include medication management, injection therapies, and intrathecal (spinal cord) pain pump therapy. Dr Brogan also practices at the University Pain Management Center, as a member of its interdisciplinary pain management team.


    An Irish citizen, he received his medical degree from the Royal College of Surgeons in Ireland Medical School in 1997. After a residency in Anesthesiology, Dr Brogan did a Pain Medicine fellowship at the University of Utah, and is board-certified in Anesthesiology and in Pain Medicine.

    Board Certification and Academic Information

    Academic Departments Anesthesiology -Professor (Clinical)
    Board Certification
    American Board of Anesthesiology
    American Board of Anesthesiology (Sub: Pain Medicine)

    Education history

    Fellowship Anesthesiology - University of Utah School of Medicine Fellow
    Residency Anesthesiology - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Professional Medical Medical School - Royal College of Surgeons - Ireland M.B.B.Ch.

    Selected Publications

    Journal Article

    1. Deer TR, Hayek SM, Grider JS, Pope JE, Brogan SE, Gulati A, Hagedorn JM, Strand N, Hah J, Yaksh TL, Staats PS, Perruchoud C, Knezevic NN, Wallace MS, Pilitsis JG, Lamer TJ, Buchser E, Varshney V, Osborn J, Goel V, Simpson BA, Lopez JA, Dupoiron D, Saulino MF, McDowell GC 2nd, Piedimonte F, Levy RM (2024). The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain. Neuromodulation. (Read full publication)
    2. Gabay S, Sapir Y, Korn A, Hochberg U, Tellem R, Zegerman A, Brogan SE, Rahimpour S, Shofty B, Strauss I (2023). Optimization of Radiofrequency Needle Placement in Percutaneous Cordotomy Using Electromyography in the Deeply Sedated Patient. Oper Neurosurg, 26(1), 22-27. (Read full publication)
    3. Sindt JE, Fitzgerald LA, Kuznicki J, Prelewicz S, Odell DW, Brogan SE (2023). Antiplatelet and Wound Healing Implications of Immunotherapy and Targeted Cancer Therapies in the Perioperative Period. Anesthesiology, 139(4), 511-522. (Read full publication)
    4. Abdullah N, Sindt JE, Whittle J, Anderson JS, Odell DW, Mahan M, Brogan SE (2023). Impact of Neuromodulation on Opioid Use, Adjunct Medication Use, and Pain Control in Cancer-Related Pain: A Retrospective Case Series. Pain Med, epub ahead of print.
    5. Brogan SE, Sindt JE, Odell DW, Gulati A, Dupoiron D (2022). Controversies in intrathecal drug delivery for cancer pain. Reg Anesth Pain Med, 48(6), 319-325. (Read full publication)
    6. Brogan SE, Odell DW, Sindt JE, Yi I, Chrisman OM, Zhang C, Presson AP (2022). Dorsal vs Ventral Intrathecal Catheter Tip Location and Effect on Dose Escalation and Opioid Use in Patients With Cancer Pain. Neuromodulation, 26(6), 1233-1239. (Read full publication)
    7. Perruchoud C, Dupoiron D, Papi B, Calabrese A, Brogan SE (2022). Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies. Neuromodulation. (Read full publication)
    8. Sindt JE, Odell DW, Tariq R, Presson AP, Zhang C, Brogan SE (2021). Initial Intrathecal Dose Titration and Predictors of Early Dose Escalation in Patients With Cancer Using a 100:1 Oral to Intrathecal Morphine Conversion Ratio. Neuromodulation, 24(7), 1157-1166. (Read full publication)
    9. Aman MM, Mahmoud A, Deer T, Sayed D, Hagedorn JM, Brogan SE, Singh V, Gulati A, Strand N, Weisbein J, Goree JH, Xing F, Valimahomed A, Pak DJ, El Helou A, Ghosh P, Shah K, Patel V, Escobar A, Schmidt K, Shah J, Varshney V, Rosenberg W, Narang S (2021). The American Society of Pain and Neuroscience (ASPN) Best Practices and Guidelines for the Interventional Management of Cancer-Associated Pain. J Pain Res, 14, 2139-2164. (Read full publication)
    10. Brogan SE, Sindt JE, Odell DW (2021). Quantitative Assessment of the Incidence of Persistent Orthostatic Hemodynamic Changes After Celiac Plexus Neurolysis: A Prospective Case Series. A A Pract, 15(5), e01470. (Read full publication)
    11. Odell DW, Albrechtsen RD, Sindt JE, Gole R, Brown S, Parsons MW, Paxton AB, Sarkar V, Lloyd S, Brogan SE, Tao R (2021). The Effect of Measured Radiotherapy Dose on Intrathecal Drug Delivery System Function. Neuromodulation, 24(7), 1204-1208. (Read full publication)
    12. Sindt JE, Odell DW, Dalley AP, Brogan SE (2020). Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer. Neuromodulation, 23(7), 978-983. (Read full publication)
    13. Brogan SE, Sindt JE, Jackman CM, White J, Wilding V, Okifuji A (2019). Prospective Association of Serum Opioid Levels and Clinical Outcomes in Patients With Cancer Pain Treated With Intrathecal Opioid Therapy. Anesth Analg, 130(4), 1035-1044. (Read full publication)
    14. Brogan SE, Winter NB, Abiodun A, Safarpour R (2013). A cost utilization analysis of intrathecal therapy for refractory cancer pain: identifying factors associated with cost benefit. Pain Med, 14(4), 478-86. (Read full publication)
    15. Brogan SE (2006). Intrathecal therapy for the management of cancer pain. Curr Pain Headache Rep, 10(4), 254-9. (Read full publication)
    16. Brogan SE, Cahalan MK (2005). Gatifloxacin as a possible cause of serious postoperative hypoglycemia. Anesth Analg, 101(3), 635-6, table of contents. (Read full publication)